Pages that link to "Q40108303"

The following pages link to The efficiency of nonsense-mediated mRNA decay is an inherent character and varies among different cells (Q40108303):

Displaying 50 items.

• Interactions between UPF1, eRFs, PABP and the exon junction complex suggest an integrated model for mammalian NMD pathways (Q24311680) (← links)
• Identification of genes in toxicity pathways of trinucleotide-repeat RNA in C. elegans (Q30586121) (← links)
• Assessing allele-specific expression across multiple tissues from RNA-seq read data (Q30918610) (← links)
• Comparison of nonsense-mediated mRNA decay efficiency in various murine tissues (Q33390501) (← links)
• Assessing the residual CFTR gene expression in human nasal epithelium cells bearing CFTR splicing mutations causing cystic fibrosis. (Q33620824) (← links)
• The unfolded protein response affects readthrough of premature termination codons (Q33623379) (← links)
• Heritability in the efficiency of nonsense-mediated mRNA decay in humans. (Q33640185) (← links)
• Nucleosome deposition and DNA methylation may participate in the recognition of premature termination codon in nonsense-mediated mRNA decay. (Q33646294) (← links)
• Nonsense-mediated RNA decay regulation by cellular stress: implications for tumorigenesis. (Q33739414) (← links)
• When a ribosome encounters a premature termination codon (Q34049225) (← links)
• Cell type-dependent gene regulation by Staufen2 in conjunction with Upf1. (Q34075898) (← links)
• Targets for cystic fibrosis therapy: proteomic analysis and correction of mutant cystic fibrosis transmembrane conductance regulator (Q34082569) (← links)
• The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genes (Q34306268) (← links)
• The CFTR frameshift mutation 3905insT and its effect at transcript and protein level. (Q34328550) (← links)
• 5-azacytidine inhibits nonsense-mediated decay in a MYC-dependent fashion. (Q34443734) (← links)
• Nonsense-mediated decay in genetic disease: friend or foe? (Q34658988) (← links)
• Making sense of nonsense GABA(A) receptor mutations associated with genetic epilepsies (Q34789999) (← links)
• Method for quantitative analysis of nonsense-mediated mRNA decay at the single cell level (Q34906037) (← links)
• Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy (Q35069526) (← links)
• Regulation of cytoplasmic mRNA decay (Q35955726) (← links)
• Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1) (Q36280761) (← links)
• Mutation analysis of TMC1 identifies four new mutations and suggests an additional deafness gene at loci DFNA36 and DFNB7/11 (Q36519881) (← links)
• Hypoxic inhibition of nonsense-mediated RNA decay regulates gene expression and the integrated stress response (Q36711234) (← links)
• The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis (Q36815190) (← links)
• Inhibition of SMG-8, a subunit of SMG-1 kinase, ameliorates nonsense-mediated mRNA decay-exacerbated mutant phenotypes without cytotoxicity (Q37173083) (← links)
• Two molecular pathways (NMD and ERAD) contribute to a genetic epilepsy associated with the GABA(A) receptor GABRA1 PTC mutation, 975delC, S326fs328X (Q37204045) (← links)
• Regulation of nonsense-mediated mRNA decay (Q38048705) (← links)
• Inhibition of nonsense-mediated RNA decay by the tumor microenvironment promotes tumorigenesis (Q38284709) (← links)
• Repairing the basic defect in cystic fibrosis - one approach is not enough. (Q38594795) (← links)
• A novel role for CARM1 in promoting nonsense-mediated mRNA decay: potential implications for spinal muscular atrophy. (Q38812591) (← links)
• The GABRG2 nonsense mutation, Q40X, associated with Dravet syndrome activated NMD and generated a truncated subunit that was partially rescued by aminoglycoside-induced stop codon read-through. (Q39593426) (← links)
• RB1 mutations and second primary malignancies after hereditary retinoblastoma (Q39671293) (← links)
• Functional Analysis of A Novel Splicing Mutation in The Mutase Gene of Two Unrelated Pedigrees (Q41015075) (← links)
• Fibroblast growth factor signaling is required for early somatic gonad development in zebrafish. (Q41702266) (← links)
• Synthesis and activity of a novel inhibitor of nonsense-mediated mRNA decay (Q41766492) (← links)
• Slow degradation and aggregation in vitro of mutant GABAA receptor gamma2(Q351X) subunits associated with epilepsy (Q42375144) (← links)
• Molecular characterization of ten F8 splicing mutations in RNA isolated from patient's leucocytes: assessment of in silico prediction tools accuracy (Q45872764) (← links)
• Nonsense-mediated mRNA decay process in nine alleles of Niemann-Pick type C patients from Spain (Q46119282) (← links)
• Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial (Q46415131) (← links)
• U1 snRNA mis-binding: a new cause of CMT1B. (Q47710397) (← links)
• Up-Frameshift Protein UPF1 Regulates Neurospora crassa Circadian and Diurnal Growth Rhythms. (Q48031774) (← links)
• Antisense suppression of the nonsense mediated decay factor Upf3b as a potential treatment for diseases caused by nonsense mutations. (Q48241302) (← links)
• A splice-site mutation and overexpression of MYO6 cause a similar phenotype in two families with autosomal dominant hearing loss (Q50453617) (← links)
• Mechanistic Multi-Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics (Q50524228) (← links)
• A case of pancreatic agenesis and congenital heart defects with a novel GATA6 nonsense mutation: evidence of haploinsufficiency due to nonsense-mediated mRNA decay. (Q53086546) (← links)
• Mechanism of Nonsense-Mediated mRNA Decay Stimulation by Splicing Factor SRSF1. (Q55235090) (← links)
• Oculofaciocardiodental syndrome: novel BCOR mutations and expression in dental cells (Q57424619) (← links)
• A new function of ROD1 in nonsense-mediated mRNA decay (Q57618985) (← links)
• Use of PTC124 for nonsense suppression therapy targeting BMP4 nonsense variants in vitro and the bmp4st72 allele in zebrafish (Q64095307) (← links)
• Nonsense-mediated mRNA decay efficiency varies in choroideremia providing a target to boost small molecule therapeutics (Q64261224) (← links)